ARKO vs CPS

ARKO's Piotroski F-Score of 4/9 indicates weak financial health, signaling distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises red flags for potential bankruptcy risk, especially given a dangerously high Debt/Equity ratio of 7.02. While the stock trades below its Graham Number ($2.85) and intrinsic value ($1.05), it is currently priced at $5.26—well above both, suggesting a significant premium driven by speculative growth expectations. Despite strong earnings surprises in recent quarters and a 'strong_buy' analyst consensus, the company exhibits negative revenue growth (-10.7% YoY), deteriorating profitability, and a high payout ratio of 80%, undermining sustainability. The technical trend is bearish (0/100), reinforcing downward momentum.

CPS exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a negative Price-to-Book ratio of -6.80, indicating negative shareholders' equity. While the stock has seen a 1-year price surge and analysts maintain a 'buy' rating with a target of $51.88, the fundamental data shows collapsing earnings growth (-91.9%) and stagnant revenue. The disconnect between the technical price action and the deterministic health scores suggests a high-risk speculative play rather than a value investment. Liquidity is tight with a quick ratio of 0.97, barely covering short-term obligations.